Financials

  • Market Capitalization 2.46 B
  • Employee 361
  • Founded 2016
  • CEO N/A
  • Website www.veratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00Q72WYG3
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-10.87
市销率
7 992.14

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
1857
PGEN
Precigen, Inc. - Common Stock
6.95 USD-3.34%-2.80%+29.18%+54.79%2.49 B USD
1862
NKTR
Nektar Therapeutics - Common Stock
72.52 USD-2.72%-0.67%+3.57%-1.02%2.48 B USD
1880
TRVI
Trevi Therapeutics, Inc. - Common Stock
16.79 USD-6.51%-4.60%-6.93%+134.83%2.39 B USD
1885
KOD
Kodiak Sciences Inc - Common Stock
37.72 USD-3.58%-2.05%-7.82%+326.21%2.37 B USD

新闻